Back | Next |
home / stock / apri / apri message board
Subject | By | Source | When |
---|---|---|---|
Sharp dip in first 30 minutes, down 6%. 2.20. | harr449 | investorshub | 10/06/2021 2:50:33 PM |
Oct. 05, 2021 Seelos Therapeutics Should Be | harr449 | investorshub | 10/05/2021 9:29:28 PM |
Cant wait for great news so flippers | harr449 | investorshub | 09/29/2021 9:48:33 PM |
Added. | trickledownfacists | investorshub | 09/29/2021 5:24:12 PM |
WTH, abrupt .20 drop. 11:18 AM. | harr449 | investorshub | 09/29/2021 3:51:00 PM |
Upgrade ahead of this.....hmmmm. Somebody wants to look | LINK Oracle | investorshub | 09/27/2021 6:05:30 PM |
Monster | trickledownfacists | investorshub | 09/27/2021 3:13:57 PM |
ty for post. Bought 1000 shares. | harr449 | investorshub | 09/27/2021 1:38:17 PM |
Wow | harr449 | investorshub | 09/27/2021 1:33:06 PM |
Boom | trickledownfacists | investorshub | 09/27/2021 1:27:32 PM |
Big Price Target Increase! | Invest83838 | investorshub | 09/27/2021 12:45:22 PM |
$SEEL Roth Capital analyst Jonathan Aschoff upgrades Seelos | TheFinalCD | investorshub | 09/27/2021 12:41:18 PM |
That's probably correct harr449 | Invest83838 | investorshub | 09/22/2021 10:37:26 AM |
imo, people loaded up last week on news leak. | harr449 | investorshub | 09/21/2021 8:11:14 PM |
I Haven't Sold Smart Money | Invest83838 | investorshub | 09/21/2021 7:41:40 PM |
Yup, $AEZS next. | trickledownfacists | investorshub | 09/21/2021 6:14:53 PM |
$1.90-2.50's= $$$$ | TheFinalCD | investorshub | 09/21/2021 6:10:36 PM |
Ahahahahahahahahahahaha | trickledownfacists | investorshub | 09/21/2021 5:43:02 PM |
Still running | trickledownfacists | investorshub | 09/21/2021 5:37:17 PM |
DONT $SEEL https://www.massgeneral.org/news/press-release/Investigational-drug-re | TheFinalCD | investorshub | 09/21/2021 5:29:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Apricus Biosciences Inc. Company Name:
APRI Stock Symbol:
NASDAQ Market:
Apricus Biosciences Inc. Website:
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...